Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 65 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

65 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 14, 2020 ASTH P 5,000 $17.28 $86,400 690,490 Indirect +0.73% Acquired 107.6% (price as of 2026-10-02)
Sept. 9, 2020 ASTH P 5,000 $17.85 $89,250 1,814,872 Indirect +0.28% Acquired 101.0% (price as of 2026-10-02)
Aug. 27, 2020 ASTH P 5,000 $18.23 $91,150 1,776,614 Indirect +0.28% Acquired 96.8% (price as of 2026-10-02)
Nov. 14, 2019 ASTH P 10,000 $14.84 $148,400 1,743,623 Indirect +0.58% Acquired 141.8% (price as of 2026-10-02)
Aug. 15, 2019 ASTH P 4,000 $15.57 $62,280 1,668,740 Indirect +0.24% Acquired 130.4% (price as of 2026-10-02)
Aug. 15, 2019 ASTH P 6,000 $16.19 $97,140 1,674,740 Indirect +0.36% Acquired 121.6% (price as of 2026-10-02)
Aug. 14, 2019 ASTH P 7,200 $16.85 $121,320 1,664,740 Indirect +0.43% Acquired 112.9% (price as of 2026-10-02)
June 11, 2019 ASTH P 6,900 $14.64 $101,016 1,657,540 Direct +0.42% Acquired 145.1% (price as of 2026-10-02)
March 30, 2016 ASTH P 555,555 $9.00 $4,999,995 555,555 Indirect · Acquired 298.7% (price as of 2026-10-02)
March 30, 2016 ASTH P 555,555 $9.00 $4,999,995 1,666,666 Indirect +50.00% Acquired 298.7% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Dec. 8, 2025 ASTH Stock Option (right to buy) Common Stock (29,502) $17.78 Dec. 10, 2025 29,502 Disposed
Sept. 9, 2024 ASTH Stock Option (right to buy) Common Stock (28,046) $18.65 Dec. 30, 2024 28,046 Disposed
Dec. 5, 2022 ASTH Warrants to purchase Common Stock Common Stock (51,443) $10.00 Dec. 8, 2022 51,443 Disposed
Dec. 5, 2022 ASTH Warrants to purchase Common Stock Common Stock (48,586) $11.00 Dec. 8, 2022 48,586 Disposed
Nov. 2, 2021 ASTH Stock Option (right to buy) Common Stock (29,502) $71.45 Nov. 2, 2026 29,502 Acquired
March 30, 2021 ASTH Warrant to Purchase Common Stock Common Stock (31,755) $10.00 March 30, 2021 31,755 Disposed
Dec. 10, 2020 ASTH Stock Option (right to buy) Common Stock (29,502) $17.78 Dec. 10, 2025 29,502 Acquired
Sept. 8, 2020 ASTH Warrants to Purchase Common Stock Common Stock (63,510) $9.00 Oct. 14, 2020 63,510 Disposed
Dec. 30, 2019 ASTH Stock Option (right to buy) Common Stock (28,046) · Dec. 30, 2024 28,046 Acquired
Dec. 27, 2019 ASTH Stock Option (right to buy) Common Stock (39,189) · Sept. 30, 2024 39,189 Disposed
Sept. 30, 2019 ASTH Stock Option (right to buy) Common Stock (39,189) · Sept. 30, 2024 39,189 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F1,F3] Common Stock (68,317) $9.00 Oct. 14, 2020 68,317 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F1,F3] Common Stock (34,159) $10.00 March 30, 2021 34,159 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F1,F2] Common Stock (55,337) $10.00 Dec. 8, 2022 55,337 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F1,F2] Common Stock (52,263) $11.00 Dec. 8, 2022 52,263 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F2] Common Stock (63,511) $9.00 · 63,511 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F2] Common Stock (31,755) $10.00 · 31,755 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F1] Common Stock (51,444) $10.00 Dec. 8, 2022 51,444 Acquired
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F1] Common Stock (48,586) $11.00 Dec. 8, 2022 48,586 Acquired
Dec. 8, 2017 ASTH Series A Preferred Stock [F9] Common Stock (1,111,111) · · 1,111,111 Disposed
Dec. 8, 2017 ASTH Series B Preferred Stock [F9] Common Stock (555,555) · · 555,555 Disposed
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F9] Common Stock (1,111,111) $9.00 Oct. 14, 2020 1,111,111 Disposed
Dec. 8, 2017 ASTH Warrants to purchase Common Stock [F9] Common Stock (555,555) $10.00 March 30, 2021 555,555 Disposed
March 30, 2016 ASTH Series B Preferred Stock [F1] Common Stock (555,555) · · 555,555 Acquired
March 30, 2016 ASTH Warrants to purchase Common Stock [F1] Common Stock (555,555) $10.00 March 30, 2021 555,555 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 29, 2016 ASTH Common Stock [F1] · Indirect
April 29, 2016 ASTH Series A Preferred Stock→ Common Stock · Indirect
Jan. 25, 2016 ASTH Common Stock · Indirect
Jan. 25, 2016 ASTH Series A Preferred Stock→ Common Stock · Indirect
Jan. 25, 2016 ASTH Warrants to purchase Common Stock→ Common Stock · Indirect

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ASTH

CEO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2024 $950,000 · $1,878,400 · · · $14,662 $2,843,062
2022 $950,000 $450,000 · · · · $87,709 $1,487,709
2021 $950,000 · $4,661,541 $1,115,766 · · $129,887 $6,857,194

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.